The LSPN Europe 2025 Survey, which comes ahead of LSPN Europe in London in November, invites patent practitioners specialising in pharma, biotech, medical devices, diagnostics, and more to share their ...

A new law affecting disputes concerning the ‘Bolar provision’ could allow competitors to enter the Ukrainian market before a ...

15 April 2025 Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega ...

The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular ...

The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation ...

The seasoned patent litigators join from Mayer Brown, bringing decades of high-stakes experience in pharma and biotech patent ...